ALB and diabetic kidney disease: A total of 1922 participants were enrolled, of whom 1063 (55.31%), 724 (37.67%), and 339 (17.64%) patients had DKD, DKD stages 1–2 Alb, and DKD-non-Alb+DKD stage 3 Alb, respectively.